COR vs GIPL vs YI Stock Comparison

Cencora, Global Innovative Platforms and 111 Prices as of Oct 29, 2026 Peers: Industry group
1 more company in this comparison (MCK) Create a free account to keep reading and compare up to 10 companies.
COR Cencora, Inc.
$330.64 +7.5% 1M -0.8% 1Y
Market cap
$63.09B
P/E
24.3x
Revenue (TTM)
$332.77B
Div. yield
0.73%
Drug Distribution Healthcare
6 wins
YI 111, Inc.
$3.00 -14.3% 1M -31.7% 1Y
Market cap
$26.10M
P/E
–
Revenue (TTM)
$1.51B
Div. yield
–
Drug Distribution Healthcare

Head to Head

8 decided of 12

Cencora leads on 6 of the 12 questions below (Cencora 6, Global Innovative Platforms 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCORGIPLYILeader
Larger companyMarket capitalisation $63.09B $24.88M $26.10M COR
Cheaper on earningsLower P/E, profitable companies only 24.3x -36.0x -1.7x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 19.4x — — –
Faster revenue growthRevenue growth, trailing twelve months +5.1% — -23.7% COR
More profitableNet margin, trailing twelve months 0.8% -361.7% -1.0% COR
Better return on capitalReturn on invested capital 14.4% — — –
Less leveragedLower net debt / EBITDA 2.2x 0.4x — GIPL
Higher dividend yieldTrailing dividend yield 0.73% — — –
Better 1-year returnPrice return, last 12 months -0.8% -37.5% -31.7% COR
Better 5-year returnAnnualised price return, 5 years +22.1%/yr -36.9%/yr -10.4%/yr COR
Less volatileAnnualised volatility, 1 year 32.8% 270.9% 84.6% COR
Higher overall scoreMean of the five percentile scores vs peers 54/100 55/100 21/100 GIPL

Percentile Scorecard

CORGIPLYI

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCORGIPLYI
Valuation 63 #10 of 25 62 #237 of 624 25 #19 of 25
Growth 74 #7 of 24 27 #438 of 601 22 #19 of 24
Profitability 61 #10 of 24 40 #327 of 541 26 #18 of 24
Financial Health 24 #20 of 26 98 #12 of 647 12 #23 of 26
Shareholder Returns 47 #9 of 16 50 #181 of 359 –
Overall 54 55 21
  • COR ranked among 27 companies in Healthcare Payers and Distributors
  • GIPL ranked among 671 companies in Pharmaceuticals and Biotechnology
  • YI ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCORGIPLYISPY
1 month +7.5%0.0%-14.3% +0.7%
3 months +5.9%0.0%-22.1% +3.7%
6 months +7.3%-3.8%-51.6% +7.1%
Year to date -2.1%+354.5%+17.2% +12.8%
1 year -0.8%-37.5%-31.7% +11.9%
3 years +78.3%-52.4%+33.3% +85.2%
3 years, per year +21.3%-21.9%+10.1% +22.8%
5 years +171.0%-90.0%-42.3% +67.6%
5 years, per year +22.1%-36.9%-10.4% +10.9%
10 years +378.2%-79.2%— +262.0%
10 years, per year +16.9%-14.5%— +13.7%

Risk

MeasureCORGIPLYISPY
Volatility, 1Y 32.8%270.9%84.6% 12.7%
Downside volatility, 1Y 39.7%—68.8% 12.6%
Beta vs S&P 500, 1Y -0.162.260.27 1.00
Return / volatility, 1Y -0.02-0.14-0.37 0.94
Max drawdown, 5Y -32.6%-98.0%-92.4% -25.4%
From 52-week high -11.8%-49.5%-64.2% -1.2%
52-week high $374.75$0.99$8.38 $779.14
52-week low $252.74$0.11$2.56 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCORGIPLYI
P/E now vs peer median 24.3xmedian 24.3x -36.0xmedian 17.8x -1.7xmedian 24.3x
P/S now vs peer median 0.2xmedian 0.3x 132.9xmedian 9.1x 0.0xmedian 0.3x
EV/EBITDA now vs peer median 17.5xmedian 12.9x -39.5xmedian 15.0x —median 12.9x
P/FCF now vs peer median 15.5xmedian 16.4x -32.5xmedian 21.7x -4.9xmedian 16.4x
P/B now vs peer median 19.5xmedian 2.5x 46.8xmedian 2.2x -0.2xmedian 2.5x
PEG now vs peer median 1.36median 1.36 -0.57median 0.35 -0.06median 1.36

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCORGIPLYI
Revenue $332.77B $187.20K $1.51B
Gross profit $13.22B – $86.34M
Operating income $3.04B -$677.04K -$6.69M
Net income $2.65B -$677.04K -$9.68M
Free cash flow $4.06B -$766.04K -$5.36M
R&D – $377.99K –
EPS (diluted) $13.53 $-0.02 $-1.76
Cash & equivalents $2.82B $244.24K $43.51M
Total debt $11.72B $8.62K $38.32M
Shares (diluted) 193.94M 44.54M 8.70M
Enterprise value $52.18B $24.27M -$87.87M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCORGIPLYI
P/E 24.3x -36.0x -1.7x
P/FCF 15.5x -32.5x -4.9x
P/Operating cash flow 13.1x -35.0x -4.9x
P/S 0.2x 132.9x 0.0x
P/B 19.5x 46.8x -0.2x
P/Tangible book -23.4x 47.1x -0.2x
EV/EBITDA 17.5x -39.5x –
EV/EBIT 23.7x -36.4x -1.8x
EV/Revenue 0.2x 131.6x 0.0x
EV/FCF 17.7x -32.2x -2.3x
EV/Operating cash flow 14.9x -34.7x -2.3x
PEG (3Y EPS CAGR) 1.36 -0.57 -0.06

Growth

14 metrics
MetricCORGIPLYI
Revenue growth (1Y) 5.1% – -23.7%
Revenue CAGR (3Y) 9.4% – -10.3%
Gross profit growth (1Y) 20.0% – -21.9%
Gross profit CAGR (3Y) 15.0% – -12.3%
Operating income growth (1Y) 11.1% -20.9% -958.5%
Operating income CAGR (3Y) 9.5% -51.6% 42.9%
Net income growth (1Y) 38.9% -20.9% -128.6%
Net income CAGR (3Y) 16.2% -51.6% 35.6%
EPS growth (1Y) 39.3% -9.8% -46.2%
EPS CAGR (3Y) 17.9% 63.5% 30.0%
Operating cash flow growth (1Y) 176.7% 15.8% -133.6%
Operating cash flow CAGR (3Y) 14.1% -96.8% 43.3%
Free cash flow growth (1Y) 255.7% 9.2% -133.6%
Free cash flow CAGR (3Y) 13.3% -101.8% 43.3%

Profitability

14 metrics
MetricCORGIPLYI
Gross margin 4.0% – 5.7%
EBITDA margin 1.2% -333.4% –
Operating margin 0.9% -361.7% -0.4%
Pretax margin 1.1% -361.7% -0.6%
Net margin 0.8% -361.7% -1.0%
FCF margin 1.2% -409.2% -0.4%
Operating cash flow margin 1.4% -379.8% -0.4%
Return on equity 77.4% -120.8% –
Return on assets 3.2% -119.7% -3.6%
Return on invested capital 14.4% – –
Return on capital employed 12.9% -121.4% -18.9%
Asset turnover 4.0x 0.3x 5.5x
Cash conversion (OCF / net income) 1.8x 1.1x 0.6x
Stock comp / revenue 0.0% – –

Financial Health

11 metrics
MetricCORGIPLYI
Debt / assets 14.0% 1.0% 14.5%
Debt / equity 3.6x 0.0x -0.3x
Net debt / EBITDA 2.2x 0.4x –
Debt / FCF 2.9x 0.0x -7.1x
Liabilities / assets 96.1% 1.4% 143.4%
Equity / assets 3.9% 98.6% -43.4%
Interest coverage – – -1.3x
Current ratio 0.9x 34.7x 1.1x
Quick ratio 0.5x 33.2x 0.3x
Cash ratio 0.0x 31.3x 0.2x
Altman Z-score 4.66 1,908 2.60

Shareholder Returns

7 metrics
MetricCORGIPLYI
Dividend yield 0.7% – –
Net buyback yield 1.6% -3.2% –
Shareholder yield 2.3% -3.2% –
Payout ratio (earnings) 17.7% – –
Payout ratio (FCF) 11.5% – –
Dividend growth (1Y) 8.7% – –
Dividend CAGR (3Y) 5.7% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCORGIPLYI
Forward P/E 19.4xFY2026 – –
EPS, next fiscal year $17.08FY2026 – $-2.92FY2027
EPS growth, next FY +6.7%FY2026 – –
EPS growth, the year after +11.8% – –
Revenue, next fiscal year $328.56BFY2026 – $2.51BFY2026
Revenue growth, next FY +2.2%FY2026 – +39.6%FY2026
Revenue growth, the year after -0.3% – +23.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCORGIPLYI
Held by institutions 94.7% – –
Institutions holding 1,344 – –
Change in shares held, QoQ +15.7% – –
Institutions buying 542 – –
Institutions selling 611 – –
Buyers to sellers 0.89 – –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CORGIPLYI
COR 1.00 0.00 0.04
GIPL 0.00 1.00 -0.01
YI 0.04 -0.01 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, COR, GIPL and YI?

Cencora (COR) is the largest by market capitalisation: Cencora (COR) $63.09B, Global Innovative Platforms (GIPL) $24.88M, 111 (YI) $26.10M.

Which company is growing faster?

Cencora (COR) grew revenue fastest over the trailing twelve months: Cencora (COR) +5.1%, 111 (YI) -23.7%.

Which company is more profitable?

Cencora (COR) has the highest net margin (Cencora (COR) 0.8%, Global Innovative Platforms (GIPL) -361.7%, 111 (YI) -1.0%).

Which stock has performed better?

Over the past year Cencora (COR) returned the most: Cencora (COR) -0.8%, Global Innovative Platforms (GIPL) -37.5%, 111 (YI) -31.7%. Over five years, Cencora (COR) compounded fastest (Cencora (COR) +22.1%/yr, Global Innovative Platforms (GIPL) -36.9%/yr, 111 (YI) -10.4%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Cencora (COR) 0.73%. Global Innovative Platforms (GIPL) and 111 (YI) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cencora (COR) has been the steadiest (Cencora (COR) 32.8%, Global Innovative Platforms (GIPL) 270.9%, 111 (YI) 84.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, COR, GIPL and YI?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cencora (COR) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.